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A B S T R A C T
Purpose: We explored the contraceptive experiences of female teens with epilepsy, including their
knowledge and perceptions of interactions between antiepileptic drugs and hormonal contraception and
contraceptive decision-making processes.
Method: From November 2012 to May 2013, we conducted one online survey (n = 114) and 12 online
focus group discussions (n = 26) with female teens with epilepsy about their contraceptive experiences
and unmet needs. Survey data were analyzed using descriptive statistics and focus group transcripts
were analyzed thematically using modiﬁed grounded theory methods.
Results: Both survey and focus group participants reported believing that interactions between epilepsy
medications and hormonal contraceptives could lead to reductions in contraceptive efﬁcacy and seizure
control. However, their knowledge about these types of medication interactions was often incomplete.
Many study participants viewed contraceptive decision making as a difﬁcult process, and some
participants reported avoiding hormonal contraceptives because of potential interactions with
antiepileptic drugs. Study participants reported relying on health care providers and parents for
contraceptive decision-making support. Focus group participants also reported they wanted health care
providers to provide more in-depth and comprehensive counseling about contraception, and that they
desired peer support with contraceptive decisions.
Conclusion: The ability to make informed contraceptive decisions is important for teens with epilepsy as
interactions between anti-epileptic drugs and hormonal contraceptives can impact seizure occurrence
and lead to an increased risk of unplanned pregnancy. Guidance for providers offering contraceptive care
to this population is needed, as well as a contraceptive support tool that empowers teens with epilepsy to
advocate for desired health care.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Epilepsy is a common, chronic, and often stigmatized neuro-
logical condition characterized by recurrent, unpredictable sei-
zures. Seizures can be triggered by ﬂashing lights, noise, stress,
hormonal shifts, and other events. The primary treatment for
epilepsy is antiepileptic drugs (AEDs), which stop or reduce
seizures in approximately 70% of people. Adjunctive or alternative
treatments can be used in those with refractory seizures.1
Over one million women and girls in the United States have
epilepsy and require specialized contraceptive care due to
potential interactions between AEDs and hormonal contracep-
tives.2 These medication interactions can lead to reductions in the
efﬁcacy of hormonal contraceptives, putting women at increased* Corresponding author. Tel.: +1 617 349 0040; fax: +1 617 349 0041.
E-mail address: adennis@ibisreproductivehealth.org (A. Dennis).
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights rerisk of unplanned pregnancy.3 Unplanned pregnancy is of
particular concern in this population as hormones brought about
by pregnancy can impact seizure frequency and AED use during
pregnancy can double the risk of fetal anomaly.4 Further,
medication interactions can lead to increased seizure activity,5
increasing the risks of morbidity and mortality and decreasing
quality of life.1 At the same time, some limited research suggests
that hormonal contraceptives that keep hormones in a steady state
can help alleviate hormonally induced seizures.6
Despite the serious implications of drug interactions, research
shows that adult women with epilepsy are largely unaware of
interactions between AEDs and hormonal contraceptives and face
challenges obtaining accurate information about them.7–9 Several
studies have found that most women with epilepsy have never
received information about medication interactions8–11 and that
health care providers working with this population have limited
knowledge about their contraceptive needs.8,12–17 Given these
challenges, it is unsurprising that women with epilepsy have lowerserved.
a One participant was 19 at the time of recruitment and had turned 20 by the time
of the focus group.
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population.18
There is a dearth of research investigating if female teens with
epilepsy experience the same challenges accessing appropriate
contraceptive care as their adult counterparts. While many teens,
regardless of health status, experience difﬁculties accessing high-
quality contraceptive care,19 data indicate that teens with chronic
health conditions are less likely to receive information about
sexual and reproductive health from their health care providers.20
Further, despite going to the doctor more often than the general
population, teens with chronic health conditions are less likely to
receive high-quality health care.21
Given that adolescence is a sensitive developmental period, that
teens with chronic health issues face barriers accessing high-quality
contraceptive care,20,21 and that contraceptive use among teens with
epilepsy has serious implications for neurological and reproductive
health, investigation into their contraceptive experiences is neces-
sary. Additionally, as more people in the United States (US) take
prescription medications for chronic health conditions, issues
related to medication interactions are increasingly relevant for a
larger population. To date, no identiﬁable study has investigated the
contraceptive experiences of female teens with epilepsy. To ﬁll this
gap in the literature, we conducted an online survey and online focus
groups with female teens with epilepsy to better understand their:
(1) knowledge and perceptions of interactions between AEDs and
hormonal contraception; (2) contraceptive decision-making and
experiences; (3) contraceptive supports; and (4) recommendations
for improving contraceptive service-delivery.
2. Materials and methods
A two-step, mixed-methods study was selected for this
investigation to allow for the development of a rich and nuanced
understanding of the contraceptive needs of teens with epilepsy.
The ﬁrst phase of the study, conducted from November 2012 to
December 2012, consisted of an online survey with female teens
with epilepsy. The second phase of the study, conducted from
January 2013 to May 2013, consisted of online focus group
discussions with female teens with epilepsy. The study was
approved by the Allendale Investigational Review Board.
Both phases of the study were conducted online and used
Facebook as a recruitment method. These online research methods
were selected because 95% of US teens use the Internet22 and 73%
use Facebook.23 Further, among qualitative methods, online, chat-
based focus groups were selected because the method has been
shown to reach hard-to-reach populations, be preferable for teens,
and facilitate disclosure of sensitive information.24–27 The number
and role of the moderators, focus group ground rules, and focus
group program and features were informed by research showing
best practices in online focus group research.25,26,28–32 Addition-
ally, focus groups were limited to three participants, as previous
research has shown that smaller group size is easier to manage
online while still encouraging rich discussion.25
Participants in both phases of the study were asked questions
about their epilepsy history; dating experiences; contraceptive
and pregnancy history and experiences; knowledge and percep-
tions about contraceptive and pregnancy issues for females with
epilepsy; and preferences for decision-making support around
contraception and pregnancy. This analysis focuses on the
contraceptive ﬁndings.
For the online survey, a convenience sample was recruited
through Facebook advertisements and online youth- and epilepsy-
focused Facebook groups. Female teens; diagnosed with epilepsy;
age 13–19 at the time of initial contact; ﬂuent in English; and who,
if younger than 18, had previously sought contraception or
experienced pregnancy in one of the 25 US states where minorswho have sought contraception or experienced pregnancy can
participate in research without parental consent, were eligible to
participate.33 To ensure that the individuals did not take the survey
multiple times, we removed responses that came from duplicate IP
and email addresses, and had the exact same survey responses,
especially to open-ended questions.
Prior to proceeding to the online survey, participants were
asked several questions assessing their eligibility, and, if eligible,
were asked to give electronic informed consent to participate. All
participants were provided with a $15 gift card for remuneration.
As the survey was exploratory, no power calculation was
conducted to determine the number of survey participants.
Instead, we recruited as many survey participants as feasible
given our time and budget limitations.34
Survey data were exported from the online survey into Excel
and then into SPSS. In SPSS, basic descriptive statistics, cross
tabulations, and measures of association were performed. Answers
to open-ended questions were exported into Word and analyzed
thematically.
For the online focus groups, a convenience sample was recruited
via Facebook advertisements, online youth- and epilepsy-focused
Facebook groups, and an epilepsy forum on Reddit. In addition,
survey participants were encouraged to participate in the online
focus groups. Eligibility criteria for the online focus groups were the
same as the online survey. Prior to entering the online focus groups,
teens ﬁlled out a brief survey assessing their eligibility, and gave
electronic informed consent to participate. All participants received
a $40 gift card as remuneration. Focus group participants were
recruited until thematic saturation was reached.35
Online focus group discussions were conducted through
Chatzy, a private, password-protected, online chat service. Two
research team members, trained in qualitative research methods,
served as moderators during the focus groups. Moderators typed
questions into the chat room and participants typed responses; no
video or audio technology was used during the focus groups.
Participants were also encouraged to respond to each other’s
comments and to ask each other questions.
Focus group transcripts were populated in the chat program.
We exported the transcripts and then analyzed thematically in
ATLAS.ti 6.2 (Scientiﬁc Software Development, Berlin, Germany)
using modiﬁed grounded theory methods.36 Two researchers
coded each transcript to ensure inter-coder reliability. Initial codes
were developed a priori based on focus group questions and
subsequent revisions were made to the codebook as new inductive
themes surfaced. Codes were summarized and organized themati-
cally with representative quotes extracted. Illustrative quotes were
identiﬁed for all major themes, and minor spelling and grammar
issues were corrected for readability. Quotations are identiﬁed by
participant’s pseudonym and age.
3. Results
3.1. Survey and focus group participant characteristics
One hundred fourteen teens participated in the online survey.
Survey participants were on average 18 years old (range 13–19).
The majority of survey participants self-identiﬁed as White (84%)
and non-Latina (88%). Participants reported having a variety of
seizure types and almost all reported use of AEDs (Table 1).
Twenty-six participants took part in 12 online focus groups.
Focus group participants were on average 19 years old (range
15–20)a and the majority self-identiﬁed as White (73%) and non-
Latina (96%). As with survey respondents, focus group participants
Table 1
Survey and focus group participant characteristics.
Survey sample
(n = 114)
Focus group
sample (n = 26)
Age, mean (range) 18 (13–19) 19 (15–20)
Ethnicity, n (%)a
Latina 11 (11) 1 (4)
Non-Latina 88 (89) 25 (96)
Race, n (%)a,b
American Indian or Alaskan
native
7 (6) 0 (0)
Asian 3 (3) 0 (0)
Black or African American 6 (5) 1 (4)
Native Hawaiian or other
Paciﬁc Islander
1 (1) 1 (4)
White 100 (84) 19 (73)
Other 2 (2) 3 (12)
Seizure type, n (%)a,b
Convulsive 46 (41) 8 (31)
Non-convulsive 29 (26) 3 (12)
Both convulsive and
non-convulsive
31 (28) 14 (54)
Unsure 5 (5) 1 (4)
Use of epilepsy medication,
n (%)b
97 (87) 15 (58)
Sexually active, n (%)b 66 (57) 15 (58)
Contraception use, n (%)a,b
Intrauterine devices 4 (4) 2 (8)
Implant 3 (3) 0 (0)
Shot 7 (7) 5 (19)
Vaginal ring 3 (3) 0 (0)
Patch 3 (3) 1 (4)
Oral contraceptive pills 50 (49) 12 (46)
Male condom 54 (52) 0 (0)
Female condom/cervical
barriers
1 (1) 17 (65)
Fertility-based awareness
methods
0 (0) 1(4)
Emergency contraception 9 (9) 5 (19)
Withdrawal 23 (22) 2 (8)
Foam/jelly/cream 1 (1) 1 (4)
Never use 33 (32) 7 (27)
Been pregnant 4 (4) 4 (15)
a Missing responses.
b Participants could select more than one response; percents may not add up to
100.
Table 2
Contraceptive experiences among survey participants.
Overall samplea n = 75
Reason for using contraception, n (%)b,c
Preventing pregnancy 49 (65)
Regulating period 46 (61)
Reducing cramps/pain 34 (45)
Preventing STIs/STDs 25 (33)
Treating acne 18 (24)
Reducing seizures 9 (12)
Other 4 (5)
Treating endometriosis 3 (4)
When I ﬁrst went on birth control. . .b
I felt unsure about what to do, n (%)
Yes 16 (23)
No 52 (74)
Unsure 3 (4)
I was worried what could go wrong, n (%)
Yes 37 (53)
No 32 (46)
Unsure 1 (1)
I changed my mind a lot about which birth
control method to use, n (%)
Yes 20 (29)
No 48 (69)
Unsure 2 (3)
I changed my mind a lot about whether to be
on birth control, n (%)
Yes 19 (27)
No 50 (71)
Unsure 2 (3)
I delayed picking a birth control method, n (%)
Yes 12 (17)
No 57 (81)
Unsure 2 (3)
I delayed starting birth control, n (%)
Yes 13 (19)
No 57 (81)
Unsure 1 (1)
Changes in seizures while using contraception, n (%)b
Yes 13 (17)
No 43 (57)
Unsure 19 (25)
Type of changes in seizures while using
contraception, n (%)b,c
Decreased frequency of seizures 6 (46)
Increased frequency of seizures 5 (39)
Decreased severity of seizures 4 (31)
Increased severity of seizures 2 (15)
Changed type of seizure 1 (8)
Unsure 1 (8)
Other 1 (8)
Type of contraception used when experienced changes
in seizures, n (%)c
Intrauterine devices 0 (0)
Implant 1 (8)
Shot 3 (23)
Vaginal ring 0 (0)
Patch 1 (8)
Oral contraceptive pills 7 (54)
Male condom 4 (31)
Female condom/cervical barriers 0 (0)
Fertility-based awareness methods 0 (0)
Emergency contraception 0 (0)
Withdrawal 2 (15)
Foam/jelly/cream 0 (0)
a Number reporting contraceptive use.
b Missing responses.
c Participants could select more than one response; percents may not
add up to 100.
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use of AEDs (Table 1).
3.2. Contraceptive use
Over half of survey and focus group participants reported being
sexually active. The majority of survey and focus group partici-
pants reported having used contraception. Survey and focus group
participants indicated use of a variety of contraceptive methods,
most commonly oral contraceptive pills (Table 1).
Sixty-ﬁve percent of survey participants reported their primary
reason for using contraception was pregnancy prevention. Survey
participants also commonly related using birth control to
experience non-contraceptive beneﬁts, including period regula-
tion (61%) and reduction of menstrual cramps and pain (45%)
(Table 2). Focus group participants reported using contraception
for similar reasons and that they considered the speciﬁc features of
methods when making contraceptive decisions, including the
mode of delivery, effectiveness, duration of effectiveness, accessi-
bility, and affordability.
3.3. Knowledge and perceptions of interactions between AEDs and
contraception
The majority of survey participants indicated that AEDs could
reduce the efﬁcacy of hormonal contraceptives (71%) (Table 3).Focus group participants shared similar beliefs, with many stating
something similar to what Natalie, age 15, said: that her ‘‘medicine
interferes with birth control.’’ Additionally, the majority of survey
participants reported that interactions between hormonal contra-
ceptives and AEDs could increase seizure activity (66%) (Table 3). A
Table 3
Contraceptive knowledge among survey par-
ticipants.
Overall sample n = 104
Some epilepsy medications
make birth control less
effective, n (%)
True 74 (71)
False 1 (1)
Unsure 29 (28)
Some types of birth control
can lead to an increase in
seizures, n (%)
True 69 (66)
False 5 (5)
Unsure 30 (29)
Some types of birth control
can help reduce seizures,
n (%)
True 33 (32)
False 25 (24)
Unsure 46 (44)
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reported that hormonal contraceptives could affect their medica-
tion and ‘‘make seizures go nuts’’ (Megan, age 19).
Further, survey and focus group participants often expressed
that the outcome of medication interactions was not only
reductions in contraceptive efﬁcacy or seizure control, but
reductions in both. In write-in responses, survey participants
stated that hormonal contraceptives and AEDs generally ‘‘clashed’’
or ‘‘cancel[ed] each other out.’’ One focus group participant
summed the issue up saying: ‘‘Not only would the birth control
affect the medicine, but vice versa. Basically, I’d end up seizing and
pregnant’’ (Lauren, age 19).
There was also a notable amount of uncertainty about the above
issues. Close to one-third of survey participants were unsure if
AEDs render contraceptives less effective, 29% were unsure if
contraceptives increase seizures, and 44% were unsure if contra-
ceptives reduce seizures (Table 3). Confusion about interactions
also emerged in the focus groups. One participant explained, ‘‘[I’m]
clueless/unsure what does birth control actually DO to cause
seizures’’ (Amy, age 15).
3.4. Epilepsy-related contraceptive experiences
Few study participants reported experiencing reductions in
contraceptive efﬁcacy while using AEDs and hormonal contra-
ceptives. Only four survey participants reported having experi-
enced a pregnancy and indicated they were either not using
contraception or a hormonal method at the time of pregnancy.
Similarly, only four focus group participants reported having ever
been pregnant. However, a small number of focus group
participants reported experiencing signs of reductions in con-
traceptive efﬁcacy due to medication interactions. One participant
related: ‘‘My OB/GYN told me over and over that it [birth control]
wouldn’t interfere [with AEDs]. . .. I had a pregnancy scare twice. . ..
It turned out my meds decreased the chances of them working’’
(Megan, age 19).
A minority of study participants reported that medication
interactions affected their seizures. Seventeen percent of survey
participants reported experiencing changes in seizures while on
contraception and most reported using oral contraceptive pills
when seizure changes occurred. No clear pattern emerged about
how seizures were impacted, as some participants reported their
seizure activity both worsened and improved (Table 2). Only a
minority of focus group participants experienced changes in
seizure occurrence while using hormonal contraception. Theseparticipants were using a variety of hormonal contraceptives and
most reported they experienced an increase in seizures.
3.5. Role of epilepsy in contraceptive decision-making
Concerns about medication interactions inﬂuenced partici-
pants’ contraceptive decision-making. When ﬁrst starting contra-
ception, the majority of survey respondents reported they worried
about what could go wrong (53%) (Table 2). During focus groups,
participants described contraceptive decision-making as an
involved process complicated by their perceptions that no
particular contraceptive method works best for people with
epilepsy. Further, focus group participants reported that identify-
ing the appropriate combination of contraceptives and AEDs
required undesired trial and error. One participant explained, ‘‘It
takes a while to ﬁnd one [a contraceptive method] that ﬁts you as a
female, and on top of that, one that is gonna work with our meds’’
(Haley, age 18).
A third of survey participants reported that epilepsy impacted
their decision to initiate contraception and impacted the type of
contraception they use (Table 2). When asked to explain how
epilepsy inﬂuenced their contraceptive decisions, survey partici-
pants responded that they avoided hormonal contraceptives out of
fear of how the medications would interact. Similarly, some focus
group participants reported avoiding hormonal contraception
altogether and said they relied on non-hormonal methods to avoid
any impact on seizures: ‘‘My boyfriend and I have been together for
about a year and, while we would really like for me to be on a
hormonal birth control, we both agree we’d rather not take the
chance of a seizure’’ (Lauren, age 19).
3.6. Health care providers as contraceptive decision supports
Forty-one percent of survey participants reported that a doctor
had talked to them about contraception. Among these participants,
83% reported having discussed contraception with an epilepsy
specialist, 44% with a women’s health care provider, and 42% with a
primary care provider (Table 4).
During focus groups, some participants reported having
discussed contraception with a doctor. For these participants,
health care providers, and particularly epilepsy specialists,
emerged as key resources when considering, starting, stopping,
or changing contraceptives. Generally, focus group participants
reported satisfaction with the contraceptive counseling they
received. However, they also related that discussions with health
care providers about contraception were limited in scope and
centered on the importance of preventing unplanned pregnancy
because of the risks that an unplanned pregnancy can pose to
someone with epilepsy and their fetus. One participant explained,
‘‘I’ve mostly heard [from my doctor] about actually getting
pregnant and the way the meds [AEDs] can cause birth defects’’
(Kelsey, age 19). Focus group participants desired more in-depth
counseling and expressed frustration with their doctors’ lack of
communication regarding the interactions between contraception,
AEDs, and seizure control. One participant explained, ‘‘Well, my
doctors never said much about sex. . .. I was never told if it was okay
to take birth control or if it would mess with my meds or seizures. I
was so confused’’ (Megan, age 19).
In addition, some focus group participants reported they were
given incorrect information about both general and epilepsy-
speciﬁc contraceptive issues from their doctors, which interfered
with their abilities to make informed contraceptive decisions. A
small number of participants pointed to poor guidance from
providers as a key factor that led to an inability to take advantage of
the non-contraceptive beneﬁts of birth control, or loss of seizure
control and unplanned pregnancy. Further, a few participants
Table 4
Health care provider and parental involvement in survey participants’ contracep-
tive care.
Overall sample n = 104
Talked to a doctor about birth control
or pregnancy prevention, n (%)a
Yes 42 (41)
No 55 (53)
Unsure 6 (6)
Type of doctor talked to about birth
control or pregnancy prevention, n (%)a,b
Specializes in epilepsy 34 (83)
Specializes in women’s health 18 (44)
Regular doctor 17 (42)
I wish a doctor would tell me more about
birth control for women with epilepsy,
n (%)a
Yes 53 (52)
No 28 (27)
Unsure 21 (21)
How often is parent/guardian in room when
talk to doctor about birth control, n (%)a
Always 20 (49)
Sometimes 11 (27)
Rarely 6 (15)
Never 4 (10)
When I/If I go to the doctor for information about
birth control, I wish my parent/guardian
would. . ., n (%)a,b
Come with me into the doctor’s ofﬁce 60 (57)
Stay in the waiting room 45 (43)
Drop me off at appointment, but not come inside 8 (8)
Not be involved at all 19 (18)
Unsure 3 (3)
Received information about birth control or
pregnancy prevention from parent/guardian,
n (%)a
65 (63)
a Missing responses.
b Participants could select more than one response; percents may not add up to
100.
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information about contraception from their doctors:
I have 2 doctors I see for epilepsy. . .and they both have different
feelings about it. The neurologist thinks I should just use
condoms. . .because he thinks that it [the pill] will change my
hormones. . .and the epileptologist thinks I should get on it [the
pill] so I don’t get pregnant. I don’t know (Jennifer, age 18).
3.7. Parents as contraceptive decision supports
The majority of survey participants (76%) reported that a parent
was always or sometimes in the room when they talked to their
health care providers about contraception and that they generally
preferred parents being involved in their contraceptive appoint-
ments (57%). Further, 63% of participants reported having received
information about contraception from their parents (Table 4).
Like survey participants, most focus group participants
reported having discussed contraception with their parents and
described their mothers, in particular, as important sources of
contraceptive support. Teens reported a parent helped them
understand how contraceptives might impact their epilepsy or
other health concerns, such as polycystic ovary syndrome [PCOS].
Parents were described as important advocates who asked doctors
questions about epilepsy and contraception that teens might not
have known to ask or felt comfortable asking. One participant
explained, ‘‘I feel completely comfortable with her [mother] there
[in the doctor’s ofﬁce]. She highly pushed for it [birth control] after
my PCOS diagnosis. . .. but I wouldn’t have been as aggressive about
it because I’m shyer’’ (Rebecca, age 19).Focus group participants’ comfort with parental involvement in
their contraceptive decisions seemed to stem from being used to
having their parents involved in their epilepsy care, and because
they were on their parent’s insurance. One participant explained,
I rely on my parents a lot, and need them to be ﬁlled in with all
of the information the doctor is giving me. There haven’t really
been times when I’ve wanted them out of the room while
talking to the doctor. I need my parents there, it’s me and them
ﬁghting my epilepsy. It’s easier with my parents there.
(Monique, age 19)
Although parents were often involved in focus group partici-
pants’ decisions around contraception, teens emphasized that they
saw their ﬁnal contraceptive decision as their own. They also
stressed the importance of conﬁdentiality for other teens without
supportive parents or who felt uncomfortable opening up to a
doctor about sexual activity in front of a parent.
3.8. Participant recommendations for better contraceptive care
Most survey participants (52%) and focus group participants
stated that they wished their health care providers would tell them
more about contraceptive issues for females with epilepsy
(Table 4). One focus group participant described her desire for
more information: ‘‘I would like to have more resources on how
birth control will negatively affect me as a person with epilepsy
and how it will beneﬁt. Maybe what the best brands are if you have
seizures’’ (Megan, age 19).
In addition to wanting contraceptive information, focus group
participants also reported a desire for more contraceptive support
systems, as they felt often felt unsure of where to go for
comprehensive information that addresses their speciﬁc con-
traceptive needs. One participant explained,
I feel very uninformed. I wish my doctors would give me more
information on the effects my medication plus birth control
would have. I research it on the internet but sometimes the
information just contradicts each other. I don’t know anyone
else with epilepsy so I have no one to ask’’ (Olivia, age 19).
Like the above participant, many other teens noted that outside of
the online focus groups they had never talked to other teens with
epilepsy. Teens commonly described having epilepsy as isolating
and reported that it was powerful to communicate about epilepsy
and contraception with others with epilepsy: ‘‘I thought the chat
was therapeutic honestly. It’s nice to talk to someone in the same
boat as I’’ (Jennifer, age 18).
4. Discussion
The ability to make informed contraceptive decisions is
important for teens with epilepsy as interactions between AEDs
and hormonal contraceptives can lead to an increased risk of
unplanned pregnancy and seizure occurrence, and because of the
potential for some hormonal contraceptives to improve seizure
control.3,5,6,37 In this study, participants reported incomplete
knowledge of and confusion surrounding the potential risks and
beneﬁts associated with taking AEDs and hormonal contraception.
At the same time, participants described a number of concerns
about hormonal contraceptive use that they felt made identifying
an appropriate contraceptive difﬁcult and severely limited their
contraceptive options. These participants were often unaware or
unsure about the potential for using hormonal contraceptives to
improve seizure control. Taken together, these ﬁndings suggest
that teens with epilepsy lack the appropriate information to make
informed contraceptive decisions and that they often view using
contraception as a risky endeavor.
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meeting the contraceptive needs of teens with epilepsy. First,
while participants reported that health care providers are critical
sources of contraceptive information, gaps in provider knowledge
about contraceptive issues for teens with epilepsy appear to
present barriers to high-quality contraceptive care, suggesting a
need for guidance for providers offering contraceptive care to this
population. Notably, existing guidelines from the neurological
community on the reproductive health needs of females with
epilepsy only address the needs of adult women and focus
exclusively on pregnancy.4 The 2010 release of the CDC’s United
States Medical Eligibility Criteria (US MEC), which offers guidance
to health care providers offering contraceptive counseling to
women with medical conditions and speciﬁc characteristics,
represents a critical step toward addressing provider knowledge.38
However, because the US MEC addresses a broad array of health
conditions, it is limited in depth regarding the contraceptive needs
of those with speciﬁc conditions. Speciﬁc in-depth guidance for
health care providers supporting contraceptive decisions of teens
with epilepsy is needed. Our results suggest that, at a minimum,
this guidance should address both the broad beneﬁts of
contraception, as well as epilepsy-speciﬁc considerations, so that
teens can make contraceptive decisions that best meet their health
care needs.
Another method for ensuring the contraceptive needs of teens
are met is to better educate and support teens themselves. The
development of a contraceptive support tool for teens, based on
existing evidence and ﬁndings from this study, has the potential to
help increase teens’ knowledge and empower them to advocate for
the health care they want and need. Such a tool should consider the
speciﬁc information gaps identiﬁed here, and would likely be most
effective and acceptable if it incorporated peer support systems.
Research suggests that peers are a main source of sexual health
information for teens,39 yet few teens in this study reported having
ever talked to other teens with epilepsy. Given that teens with
epilepsy have to navigate unique contraceptive challenges, in
addition to the same contraceptive issues as other teens, providing
this population with ways to share contraceptive experiences may
help support teens as they navigate a myriad of contraceptive
decisions. Finally, the tool should also include guidance for
discussing contraceptive needs with health care providers and
parents to help teens navigate an increasingly complex health care
system.
This study has several limitations. First, the non-representative
nature of the study population and self-selection of participants
limits the study’s generalizability. Study participants were on
average 18 or 19 years old and ﬁndings may not be applicable to
younger teens. Second, this study is subject to recall bias, as teens
were reporting information based on past experiences. Despite
these limitations, this study provides new, rich data on experiences
of female teens with epilepsy. Further, ﬁndings regarding the
challenges teens with epilepsy face accessing high-quality
contraceptive care are consistent with those of adult women.40
5. Conclusion
This study found that female teens with epilepsy lack the
necessary information and support to make informed contracep-
tive decisions which is troubling given that interactions between
AEDs and hormonal contraceptives can lead to increased risk of
unplanned pregnancy and seizure occurrence. Efforts are needed to
better meet the contraceptive needs of teens with epilepsy.
Findings from this study may also be useful for understanding how
teens with other chronic conditions navigate contraceptive
decisions. The use of prescription medications that affect
contraceptive efﬁcacy is common in the United States, thoughfew people taking prescription medications receive adequate
counseling about their impact on contraceptive efﬁcacy.41 Further,
AEDs are often also used to treat mental health disorders, such as
depression. Likewise, ﬁndings from this study are of relevance for
other teens with chronic health conditions whose contraceptive
needs may be unmet.
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